NANOCHON
Washington
About NANOCHON
Nanochon is a biotech and medical device company specializing in the development of innovative orthopedic solutions. The company develops medical implant technology focused on cartilage repair for patients with joint surface damage. Its primary product, Chondrograft, is a 3D-printed, synthetic implant engineered to replace lost or damaged cartilage and support the body’s own tissue repair. The design uses a nylon-based composite with structural properties intended to mimic natural cartilage and fit securely into defects using a press-fit surgical procedure. Nanochon’s solution targets individuals who require more than temporary relief but are not yet candidates for total joint replacement, offering an off-the-shelf device that integrates with the healing process. The company’s work includes advancing clinical evaluation and surgical use of its implant technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $14.3M
- Funding stage: Seed
- Last round: Seed (Jan 2026)
- Website: nanochon.com
- Phone: [email protected]
Industries & Categories
3D Printing, Biotechnology, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/nanochon-50471 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.